Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhang Qifeng Baibao Dan Capsule is a traditional Chinese medicine (TCM) therapeutic developed by Forest Ecological Agriculture (Liaocheng) Co., Ltd. for the treatment of various traumatic injuries and skin conditions. It is currently undergoing Phase II clinical evaluation in China (Trial ID: CTR20262421) for indications including skin abrasions, lacerations, contusions, thermal and chemical burns, frostbite, electric injuries, and bites from insects, dogs, or snakes. The product is designed for both oral intake and topical application, with a primary focus on achieving rapid hemostasis, pain relief, and pruritus reduction within 10 minutes of administration. As a Baibao Dan (Hundred Treasures Pill) formulation, it likely utilizes a synergistic blend of herbal ingredients to promote blood circulation and tissue repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhang Qifeng Baibao Dan Capsule.